Arcturus Therapeutics Holdings (ARCT) Consolidated Net Income: 2018-2025
Historic Consolidated Net Income for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Sep 2025 value amounting to -$13.4 million.
- Arcturus Therapeutics Holdings' Consolidated Net Income fell 94.81% to -$13.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$66.7 million, marking a year-over-year decrease of 6.57%. This contributed to the annual value of -$80.9 million for FY2024, which is 172.30% down from last year.
- According to the latest figures from Q3 2025, Arcturus Therapeutics Holdings' Consolidated Net Income is -$13.4 million, which was down 46.49% from -$9.2 million recorded in Q2 2025.
- In the past 5 years, Arcturus Therapeutics Holdings' Consolidated Net Income registered a high of $118.6 million during Q4 2022, and its lowest value of -$57.7 million during Q1 2021.
- In the last 3 years, Arcturus Therapeutics Holdings' Consolidated Net Income had a median value of -$14.1 million in 2025 and averaged -$13.4 million.
- Per our database at Business Quant, Arcturus Therapeutics Holdings' Consolidated Net Income crashed by 509.45% in 2021 and then skyrocketed by 415.16% in 2022.
- Over the past 5 years, Arcturus Therapeutics Holdings' Consolidated Net Income (Quarterly) stood at -$37.6 million in 2021, then surged by 415.16% to $118.6 million in 2022, then slumped by 109.84% to -$11.7 million in 2023, then tumbled by 156.89% to -$30.0 million in 2024, then crashed by 94.81% to -$13.4 million in 2025.
- Its Consolidated Net Income was -$13.4 million in Q3 2025, compared to -$9.2 million in Q2 2025 and -$14.1 million in Q1 2025.